<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9BA290E2-F988-418B-8B39-ED163AEE8631"><gtr:id>9BA290E2-F988-418B-8B39-ED163AEE8631</gtr:id><gtr:name>Mures County Clinical Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E2D70FF9-F1CF-4841-95BA-71F3959764AD"><gtr:id>E2D70FF9-F1CF-4841-95BA-71F3959764AD</gtr:id><gtr:name>Medical University of Warsaw</gtr:name><gtr:address><gtr:line1>Zwirki i Wigury 67</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D5939D1C-C785-4BF3-BAB3-024951ABBB01"><gtr:id>D5939D1C-C785-4BF3-BAB3-024951ABBB01</gtr:id><gtr:name>Singapore General Hospital</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:department>Sch of Medical &amp; Surgical Sciences</gtr:department><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9BA290E2-F988-418B-8B39-ED163AEE8631"><gtr:id>9BA290E2-F988-418B-8B39-ED163AEE8631</gtr:id><gtr:name>Mures County Clinical Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E2D70FF9-F1CF-4841-95BA-71F3959764AD"><gtr:id>E2D70FF9-F1CF-4841-95BA-71F3959764AD</gtr:id><gtr:name>Medical University of Warsaw</gtr:name><gtr:address><gtr:line1>Zwirki i Wigury 67</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D5939D1C-C785-4BF3-BAB3-024951ABBB01"><gtr:id>D5939D1C-C785-4BF3-BAB3-024951ABBB01</gtr:id><gtr:name>Singapore General Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/EC383F65-8919-45C4-AF30-4076C5F55E90"><gtr:id>EC383F65-8919-45C4-AF30-4076C5F55E90</gtr:id><gtr:firstName>Kennedy</gtr:firstName><gtr:surname>Lees</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/10581911-9C4A-4FB9-8328-236635EF60D9"><gtr:id>10581911-9C4A-4FB9-8328-236635EF60D9</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Whynes</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/94CCB3CD-0F1F-45F8-B609-876C1E96241A"><gtr:id>94CCB3CD-0F1F-45F8-B609-876C1E96241A</gtr:id><gtr:firstName>Philip</gtr:firstName><gtr:otherNames>Michael</gtr:otherNames><gtr:surname>Bath</gtr:surname><gtr:orcidId>0000-0003-2734-5132</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/5EA2B632-CED7-49B5-B329-51BC02C899C9"><gtr:id>5EA2B632-CED7-49B5-B329-51BC02C899C9</gtr:id><gtr:firstName>Stuart</gtr:firstName><gtr:otherNames>J</gtr:otherNames><gtr:surname>Pocock</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/070AF2F0-F5AE-4A96-B29B-FE72A23E1FF5"><gtr:id>070AF2F0-F5AE-4A96-B29B-FE72A23E1FF5</gtr:id><gtr:firstName>Joanna</gtr:firstName><gtr:surname>Wardlaw</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0501797"><gtr:id>D801C09A-A38A-48BA-803A-993F6E30D0CD</gtr:id><gtr:title>Improving the management of blood pressure in acute stroke: the Efficacy of Nitric Oxide in Stroke (ENOS) trial</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0501797</gtr:grantReference><gtr:abstractText>The Efficacy of Nitric Oxide in Stroke (ENOS) Trial examines treating high blood pressure within 48 hours of stroke. Many patients have high blood pressure immediately after a stroke and we know that these people are more likely to die or be disabled than patients with normal blood pressure. At present, doctors do not usually treat high blood pressure immediately after a stroke so this trial investigates whether or not lowering blood pressure helps people to recover. 
We are using a well-established medication called glyceryl trinitrate (GTN) which relaxes blood vessels to lower blood pressure. The trial will recruit 5,000 patients and compares patients treated with GTN for 7 days against patients who do not receive GTN. The trial also examines whether or not patients blood pressure treatment should stop or continue for 7 days. Patients are followed up by telephone call at 90 days. The main outcome is comparison of the number of patients who have died or are too disabled to care for themselves after their stroke. 
ENOS is an international trial with 52 current centres recruiting patients across 13 countries. The trial is funded by the MRC until November 2011. The University of Nottingham is the sponsor.</gtr:abstractText><gtr:technicalSummary>High blood pressure (BP 140+/90+ mmHg) affects 75+% of patients presenting with acute stroke and is independently associated with a poor outcome (increased death or dependency) and early recurrence. Lowering a high BP could improve outcome providing cerebral blood flow is not reduced. Additionally, about 50% of patients are taking antihypertensive treatment prior to their stroke but it remains unclear whether this should be continued or stopped temporarily. Our Cochrane ?Blood pressure in Acute Stroke Collaboration? review identified no completed large trials assessing these questions.

We have developed a way of lowering BP with transdermal glyceryl trinitrate (GTN, as used in patients with angina) in three small randomised controlled trials (total 145 patients) in acute/sub-acute stroke. GTN lowered BP in a controlled manner without altering cerebral blood flow or platelet function, allowed patients who were unable to swallow to be treated, was easy to administer, and appeared to be safe.

The start-up phase (395 patients recruited as at 26/09/05) of the ?Efficacy of Nitric Oxide in Stroke? (ENOS) trial is investigating the effects of GTN (5 mg daily for 7 days) versus control on safety (death, deterioration, recurrence), BP, and CT lesion size and swelling, in an international single-blind randomised controlled trial involving hypertensive patients with acute (within 48 hours) ischaemic or haemorrhagic stroke. The trial is also addressing whether prior antihypertensive therapy should be continued or stopped temporarily in relevant individuals. ENOS is the first acute stroke trial to use the internet for randomisation, data registration, and adjudication of CT scans/serious adverse events. Interim 6 monthly reviews by the Data Monitoring Committee have not identified hazard and have recommended that ENOS should continue. We now seek funding from the MRC to recruit 4600 patients (total 5000) into the main trial phase over 5 years starting April 2006. The trial will assess the effect of these interventions on functional outcome (modified Rankin Scale, primary outcome) as well as recurrence, cognition, mood and quality-of-life. Subgroup analyses will assess the interventions by stroke type, clinical syndrome, baseline BP, severity, time to randomisation, and presence of infarct swelling on CT.

Transdermal GTN is readily available, easy to administer and monitor, inexpensive (#5 per patient) and could be relevant to most patients with acute stroke. A positive large trial would benefit patients and society, reduce load on carers and health care, and contribute to the UK Government?s health strategy.</gtr:technicalSummary><gtr:fund><gtr:end>2009-09-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>4089301</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mures County Clinical Hospital</gtr:collaboratingOrganisation><gtr:country>Romania</gtr:country><gtr:description>Romania</gtr:description><gtr:id>02C8BC74-88E4-4BF1-9194-9CD431914D83</gtr:id><gtr:impact>Publication</gtr:impact><gtr:partnerContribution>Publication</gtr:partnerContribution><gtr:piContribution>Publication in print</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Singapore General Hospital</gtr:collaboratingOrganisation><gtr:country>Singapore, Republic of</gtr:country><gtr:department>Stroke Division</gtr:department><gtr:description>Singapore General Hospital</gtr:description><gtr:id>AE621B0D-4C0B-4632-A14B-A57A128C8E9A</gtr:id><gtr:impact>Publication is pending</gtr:impact><gtr:partnerContribution>Collaboration on ENOS trial and MRI publication is pending</gtr:partnerContribution><gtr:piContribution>Collaboration on ENOS trial and MRI publication is pending</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical University of Warsaw</gtr:collaboratingOrganisation><gtr:country>Poland, Republic of</gtr:country><gtr:description>Institute of Psychiatry and Neurology, Warsaw, Poland</gtr:description><gtr:id>48302426-6192-40E6-A824-67F805F34DF7</gtr:id><gtr:impact>18512165</gtr:impact><gtr:partnerContribution>Publication</gtr:partnerContribution><gtr:piContribution>Recruitment of patients to ENOS trial, acting as National Coordinator for ENOS in Poland</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>UKSF</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9B0A2A87-882F-4BD9-838E-4DF05B9D5C25</gtr:id><gtr:impact>Conference to present updates from current trials</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2010,2011,2012,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UK Stroke Forum</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>30C510F3-A791-412A-A814-CB9E9DFD84F0</gtr:id><gtr:impact>Poster presentation of the ongoing &amp;quot;STEMS2&amp;quot; trial to an audience of health professionals and lay members. Members of the press also attend this conference.

Increased public awareness of our ongoing research.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008,2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UK Stroke Forum</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6FEB5809-BA29-4EC0-A9DC-9D11425B91FA</gtr:id><gtr:impact>UKSF, SRN Events, ESC, WSC, ISC.
Talk led to questions and discussion.

Stroke conferences now regularly include patients, representatives and carers.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>https://www.stroke.org.uk/events/training-conference/uk-stroke-forum-conference-2015</gtr:url><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>684061</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2013-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>CA4DEB0A-8B41-4EEF-92A9-DE92A5CFD599</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Database</gtr:description><gtr:id>A4A2EABF-4CB0-4B82-B1D6-646142FBE273</gtr:id><gtr:impact>The use of ordinal analyses is increasingly being used in acute stroke trials.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>OAST - Tool for analysing ordinal data</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/54D8E907-FFAA-4371-8971-4465A16A7EA1"><gtr:id>54D8E907-FFAA-4371-8971-4465A16A7EA1</gtr:id><gtr:title>The NeuroGrid stroke exemplar clinical trial protocol.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a6d4944da6060d033e7b78eb9c8749e1"><gtr:id>a6d4944da6060d033e7b78eb9c8749e1</gtr:id><gtr:otherNames>Wardlaw JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AEF3750B-8C19-44CE-AFBB-D3CC674182A7"><gtr:id>AEF3750B-8C19-44CE-AFBB-D3CC674182A7</gtr:id><gtr:title>Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f91b22002b2b9192c15b2e234282538e"><gtr:id>f91b22002b2b9192c15b2e234282538e</gtr:id><gtr:otherNames>Bath PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D80B3180-41D1-4ECE-ACAC-742C0A5368F3"><gtr:id>D80B3180-41D1-4ECE-ACAC-742C0A5368F3</gtr:id><gtr:title>Calculation of numbers-needed-to-treat in parallel group trials assessing ordinal outcomes: case examples from acute stroke and stroke prevention.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1cf51488ee5c853f9d3d93449efe8316"><gtr:id>1cf51488ee5c853f9d3d93449efe8316</gtr:id><gtr:otherNames>Optimising the Analysis of Stroke Trials Collaboration with the Writing Committee</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/82A5DF34-10F4-4769-BF47-100B036F7694"><gtr:id>82A5DF34-10F4-4769-BF47-100B036F7694</gtr:id><gtr:title>A systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow.</gtr:title><gtr:parentPublicationTitle>Nitric oxide : biology and chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0f79e98da12c40ea80003dbec93edc7f"><gtr:id>0f79e98da12c40ea80003dbec93edc7f</gtr:id><gtr:otherNames>Willmot M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1089-8603</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A574651D-6FBD-411A-9E68-A5DC296054E4"><gtr:id>A574651D-6FBD-411A-9E68-A5DC296054E4</gtr:id><gtr:title>Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f91b22002b2b9192c15b2e234282538e"><gtr:id>f91b22002b2b9192c15b2e234282538e</gtr:id><gtr:otherNames>Bath PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BC9D7185-AC52-46D4-8902-C5A69F0CBD0C"><gtr:id>BC9D7185-AC52-46D4-8902-C5A69F0CBD0C</gtr:id><gtr:title>Views of paramedics on their role in an out-of-hospital ambulance-based trial in ultra-acute stroke: qualitative data from the Rapid Intervention With Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT).</gtr:title><gtr:parentPublicationTitle>Annals of emergency medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/693ab96207791cebf946f4fbb3b574f2"><gtr:id>693ab96207791cebf946f4fbb3b574f2</gtr:id><gtr:otherNames>Ankolekar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0196-0644</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B906140C-A83B-49F3-8E64-4D8263A743DA"><gtr:id>B906140C-A83B-49F3-8E64-4D8263A743DA</gtr:id><gtr:title>Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/de2da549ff6dfa73ad459c4ebff6ef34"><gtr:id>de2da549ff6dfa73ad459c4ebff6ef34</gtr:id><gtr:otherNames>ENOS Trial Investigators</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C84D3AF1-9FCE-4A3A-8268-ED25D2FB7A12"><gtr:id>C84D3AF1-9FCE-4A3A-8268-ED25D2FB7A12</gtr:id><gtr:title>Effect of the neutral CLOTS 1 trial on the use of graduated compression stockings in the Efficacy of Nitric Oxide Stroke (ENOS) trial.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/693ab96207791cebf946f4fbb3b574f2"><gtr:id>693ab96207791cebf946f4fbb3b574f2</gtr:id><gtr:otherNames>Ankolekar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F24E090D-B67D-4EC7-A7B7-46C9B4708051"><gtr:id>F24E090D-B67D-4EC7-A7B7-46C9B4708051</gtr:id><gtr:title>Glyceryl Trinitrate for Hyperacute Stroke: Results from the Efficacy of Nitric Oxide in Stroke (ENOS) Trial</gtr:title><gtr:parentPublicationTitle>STROKE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d38d3a87c9b7c83e349c9ff006b8f10a"><gtr:id>d38d3a87c9b7c83e349c9ff006b8f10a</gtr:id><gtr:otherNames>Sprigg Nikola</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3EE801EF-735D-44A9-98A8-67EF2AEBC7A9"><gtr:id>3EE801EF-735D-44A9-98A8-67EF2AEBC7A9</gtr:id><gtr:title>The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac hemodynamics, and plasma nitric oxide levels in acute stroke.</gtr:title><gtr:parentPublicationTitle>Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/043469bfd0d1b2afefc1ef3535b2c8e8"><gtr:id>043469bfd0d1b2afefc1ef3535b2c8e8</gtr:id><gtr:otherNames>Rashid P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>1052-3057</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7DC0A89C-CDC1-496A-8250-3F946C66FE31"><gtr:id>7DC0A89C-CDC1-496A-8250-3F946C66FE31</gtr:id><gtr:title>The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke.</gtr:title><gtr:parentPublicationTitle>Cerebrovascular diseases (Basel, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f91b22002b2b9192c15b2e234282538e"><gtr:id>f91b22002b2b9192c15b2e234282538e</gtr:id><gtr:otherNames>Bath PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:issn>1015-9770</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BBB42A3F-15FC-43C0-9ECE-8A09AAB94119"><gtr:id>BBB42A3F-15FC-43C0-9ECE-8A09AAB94119</gtr:id><gtr:title>High blood pressure in acute stroke and subsequent outcome: a systematic review.</gtr:title><gtr:parentPublicationTitle>Hypertension (Dallas, Tex. : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0f79e98da12c40ea80003dbec93edc7f"><gtr:id>0f79e98da12c40ea80003dbec93edc7f</gtr:id><gtr:otherNames>Willmot M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0194-911X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7645B623-14E8-4E9E-AFC4-59E154F3BD69"><gtr:id>7645B623-14E8-4E9E-AFC4-59E154F3BD69</gtr:id><gtr:title>Therapeutic Potential of Transdermal Glyceryl Trinitrate in the Management of Acute Stroke.</gtr:title><gtr:parentPublicationTitle>CNS drugs</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/44dceb389bd6cdd14d87fc1a780c5b75"><gtr:id>44dceb389bd6cdd14d87fc1a780c5b75</gtr:id><gtr:otherNames>Appleton JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1172-7047</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F0E4B51B-8F63-40BA-8519-E6C9894A6DB7"><gtr:id>F0E4B51B-8F63-40BA-8519-E6C9894A6DB7</gtr:id><gtr:title>Is lowering blood pressure hazardous in patients with significant ipsilateral carotid stenosis and acute ischaemic stroke? Interim assessment in the 'Efficacy of Nitric Oxide in Stroke' trial.</gtr:title><gtr:parentPublicationTitle>Blood pressure monitoring</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2321f20c13db6cd9828824cdd1797929"><gtr:id>2321f20c13db6cd9828824cdd1797929</gtr:id><gtr:otherNames>Sare GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1359-5237</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AFF096AA-B5EA-4F30-A6CC-1D18DE24720E"><gtr:id>AFF096AA-B5EA-4F30-A6CC-1D18DE24720E</gtr:id><gtr:title>Effect of Treatment Delay, Stroke Type, and Thrombolysis on the Effect of Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome after Acute Stroke: A Systematic Review and Meta-Analysis of Individual Patient from Randomised Trials.</gtr:title><gtr:parentPublicationTitle>Stroke research and treatment</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f91b22002b2b9192c15b2e234282538e"><gtr:id>f91b22002b2b9192c15b2e234282538e</gtr:id><gtr:otherNames>Bath PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6218CEAD-F173-484E-AC22-DE38D90D3364"><gtr:id>6218CEAD-F173-484E-AC22-DE38D90D3364</gtr:id><gtr:title>Relationship between poststroke cognition, baseline factors, and functional outcome: data from &amp;quot;efficacy of nitric oxide in stroke&amp;quot; trial.</gtr:title><gtr:parentPublicationTitle>Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/693ab96207791cebf946f4fbb3b574f2"><gtr:id>693ab96207791cebf946f4fbb3b574f2</gtr:id><gtr:otherNames>Ankolekar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1052-3057</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C3FFC4B0-377C-4259-9F26-50A97BB09176"><gtr:id>C3FFC4B0-377C-4259-9F26-50A97BB09176</gtr:id><gtr:title>Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2b24f1242edd09e829b2f2415df923c0"><gtr:id>2b24f1242edd09e829b2f2415df923c0</gtr:id><gtr:otherNames>Srivastava K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0272-4340</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/500622F9-32F3-4266-93B0-FBE122AFBE1D"><gtr:id>500622F9-32F3-4266-93B0-FBE122AFBE1D</gtr:id><gtr:title>The Efficacy Of Nitric Oxide In Stroke (ENOS) Trial - Where Do We Stand In Romania?</gtr:title><gtr:parentPublicationTitle>Romanian Journal of Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b960ef40dcad76dab2d30dc5a7a8b6ce"><gtr:id>b960ef40dcad76dab2d30dc5a7a8b6ce</gtr:id><gtr:otherNames>Szocs Ildiko</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E93851DB-AF19-4B8E-8F37-D1453DB59464"><gtr:id>E93851DB-AF19-4B8E-8F37-D1453DB59464</gtr:id><gtr:title>Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack: a prespecified secondary analysis of a randomized, placebo-controlled trial and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5428d0a2a4dadad12b13976ca900c32a"><gtr:id>5428d0a2a4dadad12b13976ca900c32a</gtr:id><gtr:otherNames>Hankey GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7473048A-05D7-41C3-9E24-1FA9B13814BB"><gtr:id>7473048A-05D7-41C3-9E24-1FA9B13814BB</gtr:id><gtr:title>The influence of stroke risk factors and comorbidities on assessment of stroke therapies in humans and animals.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/693ab96207791cebf946f4fbb3b574f2"><gtr:id>693ab96207791cebf946f4fbb3b574f2</gtr:id><gtr:otherNames>Ankolekar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8C9A4813-84B7-48C2-A568-3AEAD5A65768"><gtr:id>8C9A4813-84B7-48C2-A568-3AEAD5A65768</gtr:id><gtr:title>Continuing versus Stopping Prestroke Antihypertensive Therapy in Acute Intracerebral Hemorrhage: A Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke Trial.</gtr:title><gtr:parentPublicationTitle>Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6bc5dd3caae98b6581b175a7a2c6cc81"><gtr:id>6bc5dd3caae98b6581b175a7a2c6cc81</gtr:id><gtr:otherNames>Krishnan K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1052-3057</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1F83C7CE-FBA3-49BE-BD1F-F845068CE97F"><gtr:id>1F83C7CE-FBA3-49BE-BD1F-F845068CE97F</gtr:id><gtr:title>Plasma nitric oxide (nitrate/nitrite) levels in acute stroke and their relationship with severity and outcome.</gtr:title><gtr:parentPublicationTitle>Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/616447da8f353164431edfa215b3b932"><gtr:id>616447da8f353164431edfa215b3b932</gtr:id><gtr:otherNames>Rashid PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>1052-3057</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B2C61E62-E68D-4DE5-AE88-03A7B5821BFD"><gtr:id>B2C61E62-E68D-4DE5-AE88-03A7B5821BFD</gtr:id><gtr:title>A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine For the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): study protocol.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4abdaeb8963c908d6294c545beb41494"><gtr:id>4abdaeb8963c908d6294c545beb41494</gtr:id><gtr:otherNames>Greenan C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A880FCFD-CF36-431E-BF8D-983549BA861D"><gtr:id>A880FCFD-CF36-431E-BF8D-983549BA861D</gtr:id><gtr:title>Glyceryl Trinitrate for Acute Intracerebral Hemorrhage: Results From the Efficacy of Nitric Oxide in Stroke (ENOS) Trial, a Subgroup Analysis.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6bc5dd3caae98b6581b175a7a2c6cc81"><gtr:id>6bc5dd3caae98b6581b175a7a2c6cc81</gtr:id><gtr:otherNames>Krishnan K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BF7ED0C2-6DE4-46A7-8C4C-07203B933977"><gtr:id>BF7ED0C2-6DE4-46A7-8C4C-07203B933977</gtr:id><gtr:title>Effect of Hyperacute Administration (Within 6 Hours) of Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome After Stroke: Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke (ENOS) Trial.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/575748ea86fdabe2c6839ba975a89e0a"><gtr:id>575748ea86fdabe2c6839ba975a89e0a</gtr:id><gtr:otherNames>Woodhouse L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B25F5546-DD8A-487F-A9C0-7E59CD5FE2B8"><gtr:id>B25F5546-DD8A-487F-A9C0-7E59CD5FE2B8</gtr:id><gtr:title>Effect of the neutral CLOTS 1 trial on the use of graduated compression stockings in the Efficacy of Nitric Oxide Stroke (ENOS) trial.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/693ab96207791cebf946f4fbb3b574f2"><gtr:id>693ab96207791cebf946f4fbb3b574f2</gtr:id><gtr:otherNames>Ankolekar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/906A21A6-3610-4A08-95A0-0F81D051E2B2"><gtr:id>906A21A6-3610-4A08-95A0-0F81D051E2B2</gtr:id><gtr:title>Effect of Hyperacute Administration (Within 6 Hours) of Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome After Stroke</gtr:title><gtr:parentPublicationTitle>STROKE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/24529254e49b823571618d429ef0e0b1"><gtr:id>24529254e49b823571618d429ef0e0b1</gtr:id><gtr:otherNames>Woodhouse Lisa</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C700F106-5828-4F8E-BCF8-2DC3404FFBF1"><gtr:id>C700F106-5828-4F8E-BCF8-2DC3404FFBF1</gtr:id><gtr:title>Glyceryl trinitrate for hyperacute stroke: results from the efficacy of nitric oxide in stroke (ENOS) trial</gtr:title><gtr:parentPublicationTitle>JOURNAL OF HUMAN HYPERTENSION</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/284c697e63cdd5478a8471c0181ae070"><gtr:id>284c697e63cdd5478a8471c0181ae070</gtr:id><gtr:otherNames>Bath Philip</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0950-9240</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/53B57C76-7AC1-4665-964C-0ADA75C3281B"><gtr:id>53B57C76-7AC1-4665-964C-0ADA75C3281B</gtr:id><gtr:title>William M. Feinberg Award for Excellence in Clinical Stroke: High Explosive Treatment for Ultra-Acute Stroke: Hype of Hope.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f91b22002b2b9192c15b2e234282538e"><gtr:id>f91b22002b2b9192c15b2e234282538e</gtr:id><gtr:otherNames>Bath PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F997FA13-6219-49EC-BF4B-8FAC8A566EFA"><gtr:id>F997FA13-6219-49EC-BF4B-8FAC8A566EFA</gtr:id><gtr:title>Continuing or Temporarily Stopping Prestroke Antihypertensive Medication in Acute Stroke: An Individual Patient Data Meta-Analysis.</gtr:title><gtr:parentPublicationTitle>Hypertension (Dallas, Tex. : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/de2602304c1f025b140164afb11dd78e"><gtr:id>de2602304c1f025b140164afb11dd78e</gtr:id><gtr:otherNames>Woodhouse LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0194-911X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B486AD20-3690-4B92-AC22-C9946438A3FA"><gtr:id>B486AD20-3690-4B92-AC22-C9946438A3FA</gtr:id><gtr:title>Efficacy of Nitric Oxide in Stroke - a randomized trial. Characteristics of patients recruited in Poland.</gtr:title><gtr:parentPublicationTitle>Neurologia i neurochirurgia polska</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/33342a95a5440ee213f0804af9129157"><gtr:id>33342a95a5440ee213f0804af9129157</gtr:id><gtr:otherNames>Kobayashi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-3843</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AD4CDA7E-5DA9-46C8-B423-C78D7D50FCCE"><gtr:id>AD4CDA7E-5DA9-46C8-B423-C78D7D50FCCE</gtr:id><gtr:title>RAPID INTERVENTION WITH GLYCERYL TRINITRATE IN HYPERTENSIVE STROKE TRIAL-2 (RIGHT-2): SAFETY AND EFFICACY OF TRANSDERMAL GLYCERYL TRINITRATE, A NITRIC OXIDE DONOR</gtr:title><gtr:parentPublicationTitle>Emergency Medicine Journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e594ab9d4beb705622b0f0076a2b3ab6"><gtr:id>e594ab9d4beb705622b0f0076a2b3ab6</gtr:id><gtr:otherNames>Bath P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B856865F-03D8-41E7-8F63-D1BB8F2ABA0E"><gtr:id>B856865F-03D8-41E7-8F63-D1BB8F2ABA0E</gtr:id><gtr:title>Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122).</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/de2da549ff6dfa73ad459c4ebff6ef34"><gtr:id>de2da549ff6dfa73ad459c4ebff6ef34</gtr:id><gtr:otherNames>ENOS Trial Investigators</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/556DE73D-9BDB-4678-9D6B-A85D2AC65AC3"><gtr:id>556DE73D-9BDB-4678-9D6B-A85D2AC65AC3</gtr:id><gtr:title>Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f91b22002b2b9192c15b2e234282538e"><gtr:id>f91b22002b2b9192c15b2e234282538e</gtr:id><gtr:otherNames>Bath PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F4A7E3B3-B59E-4882-B9DB-E2C294F55DB4"><gtr:id>F4A7E3B3-B59E-4882-B9DB-E2C294F55DB4</gtr:id><gtr:title>Effect of nitric oxide donors on blood pressure and pulse pressure in acute and subacute stroke.</gtr:title><gtr:parentPublicationTitle>Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/02aa13289a46e359c07c1fd2ece2edaf"><gtr:id>02aa13289a46e359c07c1fd2ece2edaf</gtr:id><gtr:otherNames>Gray LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1052-3057</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D31E2A0D-5C56-4874-BC6A-C8C1CA3389BB"><gtr:id>D31E2A0D-5C56-4874-BC6A-C8C1CA3389BB</gtr:id><gtr:title>Letter by Bath regarding article, &amp;quot;A simple, assumption-free, and clinically interpretable approach for analysis of modified Rankin outcomes&amp;quot;.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f91b22002b2b9192c15b2e234282538e"><gtr:id>f91b22002b2b9192c15b2e234282538e</gtr:id><gtr:otherNames>Bath PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/42031F16-7A1B-4454-9D4B-E40786FD0838"><gtr:id>42031F16-7A1B-4454-9D4B-E40786FD0838</gtr:id><gtr:title>Early blood pressure lowering treatment in acute stroke. Ordinal analysis of vascular events in the Scandinavian Candesartan Acute Stroke Trial (SCAST).</gtr:title><gtr:parentPublicationTitle>Journal of hypertension</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/114e395d267b05ffaab290b1ad802aca"><gtr:id>114e395d267b05ffaab290b1ad802aca</gtr:id><gtr:otherNames>Jusufovic M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0263-6352</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501797</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>A77DAE3A-499B-4F46-971D-6C82F51F9C2E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Stroke</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>